LongCovid
Why do some people infected with COVID-19 develop postacute sequelae of COVID-19 (PASC) while others do not?
This is the question that Herman et al. try to answer with this recently published study. The article shows that the presence of functional antibodies specific to OC43 (endemic human coronavirus) was enriched in PASC, suggesting immunological imprinting specific to OC43 may be a driver of PASC, particularly in individuals with prior rheumatic disease.
The UK All-Party Parliamentary Group (APPG) on Coronavirus, an independent cross-party group, aims to ensure that lessons are learned from the UK’s handling of the coronavirus outbreak so that the UK’s…
World Health Organisation (WHO) has issued a media release on the prevalence of post COVID condition in Europe, based on modelling by the Institute for Health Metrics and Evaluation…
The Long COVID project has recently published a very interesting paper in the Journal of Psychosomatic Research. This prospective cohort study aimed to identify clinically significant clusters among…
What does the end of the emergency declaration mean for people on Medicare and food stamps in the U.S.? Dr. Eric Ding (Epidemiologist & Health Economist) talks about…